Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Clin Cancer Res. 2013 Sep 24;19(19):5494–5504. doi: 10.1158/1078-0432.CCR-13-0735

Figure 1b.

Figure 1b

Box plots of median fold increase in histone H4 acetylation in PBMC after single dose of resminostat on C1D1; maximum fold increase of histone acetylation was chosen for each patient. Dose levels 100 mg to 600 mg: N=3 each, 800 mg dose level: N=6. The lower and upper boundaries of each box define the 25th and 75th percentiles; the horizontal line in each box indicates the median; and the bars define the lowest and highest values, excluding outliers.